查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
乳房健康市场：市场规模和趋势 - 按产品、兽医保健环境、动物类型、疾病类型、地区 - 预测到 2029 年
市场调查报告书
商品编码
1515621

乳房健康市场：市场规模和趋势 - 按产品、兽医保健环境、动物类型、疾病类型、地区 - 预测到 2029 年

Udder Health Market Size, Share & Trends by Product (Pharmaceuticals, Devices, Supplements), Veterinary Care Settings, Animal Type - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 291 Pages | 订单完成后即时交付

价格

全球乳房保健市场规模预计将从2024年的12亿美元增加至2029年的16亿美元，复合年增长率为5.9%。

全球乳房保健市场的参与企业正在采取各种策略来扩大其全球足迹并增加市场占有率，例如协议、剥离、扩张和收购。

调查范围
调查年份 2021-2029
基准年 2023年
预测期 2024-2029
考虑单位 金额（十亿美元）
部分 依产品、动物医疗环境、动物类型、疾病类型、地区
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东/非洲

在乳房健康市场中，由于乳头喷雾器、乳头浸入施用器、牛奶品质分析仪和乳腺炎检测器等设备的使用不断增加，设备领域占据了第二大份额。这些设备对于维持乳牛乳房健康、预防感染疾病、确保牛奶品质发挥重要作用。酪农越来越多地采用这些工具来提高酪农生产效率和动物福利标准。需求的成长是由技术进步推动的，技术进步提高了这些设备的精度和有效性，使它们对现代酪农运作至关重要。

依动物健康环境类型划分，酪农领域在乳房健康市场中成长最快。这主要是由于中小型酪农逐渐从手工挤乳到机械化挤乳系统过渡。这种转变可以降低乳房炎等感染疾病的风险，并确保挤乳过程更加一致和卫生，有助于改善乳房健康。因此，这些酪农能够生产出高品质的牛奶，推动了这一领域的快速成长。

按动物类型划分，由于对牛奶和乳製品的需求不断增长，乳牛在乳房健康市场中占据了最大的市场占有率。乳牛对于牛奶生产至关重要，而乳房健康对于稳定供应至关重要。酪农专注于保持牛健康，以确保高品质的牛奶生产，这正在推动乳房健康产品和服务的市场。该细分市场的主导地位反映了该行业对维持牛健康的关注，以满足全球对牛奶和乳製品不断增长的需求。

该报告研究了全球乳房健康市场，包括按产品、兽医环境、动物类型、疾病类型、地区和参与市场的公司概况分類的趋势。

目录

第一章简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章市场概况

  • 介绍
  • 市场动态
  • 产业动态
  • 价值链分析
  • 技术分析
  • 波特五力分析
  • 监管状况
  • 专利分析
  • 贸易分析
  • 价格分析
  • 报销分析
  • 重大会议和活动（2024-2025）
  • 主要相关人员和采购标准
  • 乳房健康市场中未被满足的需求/最终用户期望
  • 生态系分析
  • 案例研究分析
  • 供应链分析
  • 邻近市场
  • 影响客户业务的趋势/干扰
  • 投资金筹措场景

第六章乳房健康市场，依产品

  • 介绍
  • 装置
  • 药品
  • 补充品

第七章乳房保健市场，依动物保健环境

  • 介绍
  • 酪农
  • 兽医医院和诊所

第八章乳房保健市场，依动物类型

  • 介绍
  • 乳牛
  • 其他的

第九章乳房保健市场，依疾病类型

  • 介绍
  • 临床乳腺炎
  • 其他的

第10章乳房保健市场，按地区

  • 介绍
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第十一章竞争格局

  • 概述
  • 主要参与企业的策略/秘密
  • 收益分析
  • 市场占有率分析
  • 企业评估矩阵：主要参与企业，2023
  • 企业评估矩阵：Start-Ups/小型企业，2023 年
  • 企业价值评估及财务指标
  • 主要企业研发费用
  • 品牌/产品比较
  • 竞争场景

第十二章 公司简介

  • 主要参与企业
    • VETOQUINOL SA
    • ZOETIS INC.
    • MERCK & CO., INC.
    • VIRBAC
    • ECOLAB
    • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    • ELANCO ANIMAL HEALTH INCORPORATED
    • DELAVAL
    • ORFFA
    • AHV INTERNATIONAL BV
    • BOUMATIC LLC
    • GEA GROUP AKTIENGESELLSCHAFT
    • G SHEPHERD ANIMAL HEALTH
    • CEVA SANTE ANIMALE
  • 其他公司
    • ALBERT KERBL GMBH
    • AMBIC EQUIPMENT LIMITED
    • LELY
    • ZENEX ANIMAL HEALTH INDIA PRIVATE LTD.
    • DRAMINSKI SA
    • RING BIOTECHNOLOGY CO LTD.
    • NICOSIA BIOLABS INTERNATIONAL PRIVATE LIMITED
    • BLACKMANGO HERBS
    • KORU DIAGNOSTICS LTD.
    • MASTAPLEX
    • ARBROWN CO., JP LTD.

第十三章附录

Product Code: MD 9072

The global udder health market is projected to reach USD 1.6 billion by 2029 from USD 1.2 billion in 2024 at a CAGR of 5.9%. The competitive landscape includes the analysis of the key growth strategies adopted by major players between January 2020 and May 2024. Players in the global udder health market have employed various strategies to expand their global footprint and increase their market shares such as agreements, divestitures, expansions, and acquisitions.

Scope of the Report
Years Considered for the Study2021-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD Billion)
SegmentsProduct, Veterinary Care Setting, Animal Type, and Disease Type
Regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East and Africa

"The Devices segment accounted the second-largest market share in the udder health market."

In the udder health market, the Devices segment holds the second-largest share because of the growing use of equipment like teat sprayers, teat dip applicators, milk quality analyzers, and mastitis detectors. These devices play a crucial role in maintaining the health of dairy cow udders by preventing infections and ensuring milk quality. Farmers increasingly adopt these tools to improve dairy production efficiency and animal welfare standards. The rise in demand is fueled by advancements in technology that enhance the accuracy and effectiveness of these devices, making them indispensable in modern dairy farm operations.

"Dairy farms segment of the udder health market is expected to witness the fastest CAGR."

By veterinary care setting type, the dairy farms segment has witnessed the fastest growth rate in the udder health market. This is largely because small and medium-scale dairy farms are gradually switching from manual milking to mechanized milking systems. This transition helps improve udder health by reducing the risk of infections like mastitis, ensuring more consistent and hygienic milking processes. As a result, these farms are better able to produce high-quality milk, which drives the segment's rapid growth.

"The Dairy cattle segment of the udder health market accounted for the largest market share."

Based on animal type, the dairy cattle segment accounted for the largest market share in the udder health market because of growing demand for milk and milk products. Dairy cattles are crucial for milk production, making their udder health vital for consistent supply. Farmers focus on keeping their cows healthy to ensure high-quality milk production, which drives the market for udder health products and services. This segment's dominance reflects the industry's emphasis on maintaining cow health to meet the rising global demand for milk and dairy products.

"Clinical mastitis segment of the udder health market is expected to witness the fastest CAGR."

By disease type, the clinical mastitis has experienced the fastest CAGR, in the udder health market, due to rising cases of mastitis and other related issue. The increasing prevalence of this disease has driven demand for effective treatments and management solutions within the market. As dairy farms strive to maintain herd health and productivity, there's a growing emphasis on products and practices that can prevent and treat mastitis effectively, contributing to the segment's rapid growth in the udder health industry.

"North America to have the second largest market share in the udder health market during the forecast period."

North America holds the second largest share in the udder health market. This is mainly because farmers in this region have higher incomes, allowing them to invest more in the health and care of their dairy cows. As their earnings grow, they can afford better products and services to maintain the udder health of their livestock. This increase in spending power boosts the market, making North America a significant player in this sector.

A breakdown of the primary participants (supply side) for the udder health market referred to for this report is provided below:

  • By Company Type: Tier 1-35%, Tier 2-25%, and Tier 3-40%
  • By Designation: C-level-45%, Director Level-25%, and Others-30%
  • By Region: North America-36%, Europe-26%, Asia Pacific-21%, Latin America-10%, and Middle East & Africa_ 7%

A breakdown of the primary participants (demand side) for the udder health market refer to for the report is provided below:

  • By Veterinary Care Setting Type: Dairy Farms-65%, Veterinary Hospitals and Clinics-35%
  • By Designation: Farm Owners-55%, Veterinarians-45%
  • By Region: North America-34%, Europe-27%, Asia Pacific-23%, Latin America-9%, and Middle East & Africa-7%

Key Market Players:

The prominent players in the udder health market include Vetoquinol S.A. (France), Zoetis Inc. (US), Merck & Co., Inc. (US), Virbac (France), Ecolab (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), DeLaval (Sweden), Orffa (Netherlands), AHV International (Netherlands), Boumatic LLC (US), GEA Group Aktiengesellschaft (Germany), G Shepherd Animal Health (UK), Ceva Sante Animale (France), Albert Kerbl GmbH (Germany), Ambic Equipment Limited (England), Lely (Netherlands), Zenex Animal Health India Private Limited (India), Draminski S.A. (Poland), Ring Biotechnology Co Ltd. (China), Nicosia Biolabs International Private Limited (India), Blackmango Herb (India), Koru Diagnostics Ltd. (New Zealand), Mastaplex (New Zealand), and AR Brown Co., Ltd. (Japan).

Research Coverage:

The market analysis examines the udder health market in numerous segments. It seeks to estimate the market size and growth potential across many segments, including product, veterinary care setting, animal type, disease type and geography. The study also includes a detailed competitive analysis of the market's top competitors, as well as company profiles, significant insights about their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The study will assist industry leaders/new entrants in this market by providing information on the closest approximations of the udder health market and its segments. This research will assist stakeholders understand the competitive landscape, obtaining insights to better position their firms, and developing appropriate go-to-market strategies. The study will also assist stakeholders in understanding the market pulse and obtaining information on major market drivers, constraints, opportunities, and challenges.

This report provides insights into the following pointers:

  • Analysis of key Drivers: Drivers (Increasing Demand of Milk and Dairy Products, Increasing number of veterinary practitioner in developed economies, Increasing Incidence of Mastitis and Other Udder Health Disorders, Technological Advancements in Udder Health Monitoring), Restrains (Lack of Awareness and Education Among Small-Scale Dairy Farmers), Opportunities (Gradual transitions of small and medium-scale dairy farms from manual milking to mechanized milking solutions, Increasing per capita income of farmers in developing countries), Challenges (Regulatory control on livestock industry to reduce outbreak of diseases) influencing the growth of the udder health market.
  • Market Penetration: Comprehensive information on the product portfolios of the leading companies in the udder health market. The report breaks down the market by product type, veterinary care setting types, animal types, disease types and region.
  • Product Enhancement/Innovation: Detailed information about forthcoming trends and product launches in the udder health market.
  • Market Development: Comprehensive data on attractive rising markets broken down by product category, veterinary care setting types, animal types, disease types and region.
  • Market Diversification: Comprehensive information on new products, expanding geographies, current advancements, and investments in the udder health market.
  • Competitive Assessment: In-depth analysis of market share, growth strategies, product and service offerings, and capabilities of the main udder health products manufacturers.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
    • 1.2.2 MARKET SCOPE
    • 1.2.3 YEARS CONSIDERED
    • 1.2.4 CURRENCY CONSIDERED
  • 1.3 STAKEHOLDERS
  • 1.4 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH METHODOLOGY DESIGN
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
      • 2.2.2.1 Key data from primary sources
      • 2.2.2.2 Key industry insights
  • 2.3 MARKET SIZE ESTIMATION
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5 MARKET SHARE ESTIMATION
  • 2.6 STUDY ASSUMPTIONS
  • 2.7 RESEARCH LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.7.2 SCOPE-RELATED LIMITATIONS
  • 2.8 RISK ASSESSMENT
  • 2.9 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 UDDER HEALTH MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: UDDER HEALTH MARKET, BY PRODUCT AND COUNTRY (2023)
  • 4.3 UDDER HEALTH MARKET: REGIONAL MIX
  • 4.4 UDDER HEALTH MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing demand for milk & dairy products
      • 5.2.1.2 Rising incidence of mastitis
      • 5.2.1.3 Increasing number of veterinary practitioners in developed markets and subsequent focus on preventive health measures
      • 5.2.1.4 Technological advancements in udder health monitoring devices
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Limited resources and low awareness among small-scale dairy farmers
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Gradual transition from manual milking to mechanized milking solutions
      • 5.2.3.2 Increasing per capita income of farmers in emerging markets
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Stringent regulatory guidelines for livestock industry
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 RISING DEMAND FOR ORGANIC UDDER HEALTH PRODUCTS
    • 5.3.2 INCREASING R&D ACTIVITIES FOR INNOVATIVE UDDER HEALTH SOLUTIONS
    • 5.3.3 EMPHASIS ON SUSTAINABLE PRACTICES
  • 5.4 VALUE CHAIN ANALYSIS
  • 5.5 TECHNOLOGY ANALYSIS
    • 5.5.1 KEY TECHNOLOGIES
      • 5.5.1.1 Telemedicine
      • 5.5.1.2 AI integration in udder health
    • 5.5.2 COMPLEMENTARY TECHNOLOGIES
      • 5.5.2.1 Nutritional supplements
      • 5.5.2.2 Integration of barn environmental management system
    • 5.5.3 ADJACENT TECHNOLOGIES
      • 5.5.3.1 Precision livestock farming
      • 5.5.3.2 Integration of cattle & livestock management software
  • 5.6 PORTER'S FIVE FORCES ANALYSIS
    • 5.6.1 THREAT OF NEW ENTRANTS
    • 5.6.2 BARGAINING POWER OF SUPPLIERS
    • 5.6.3 BARGAINING POWER OF BUYERS
    • 5.6.4 THREAT OF SUBSTITUTES
    • 5.6.5 COMPETITIVE RIVALRY
  • 5.7 REGULATORY LANDSCAPE
    • 5.7.1 REGULATORY ANALYSIS
    • 5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.8 PATENT ANALYSIS
    • 5.8.1 PATENT PUBLICATION TRENDS FOR UDDER HEALTH MARKET
    • 5.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.9 TRADE ANALYSIS
    • 5.9.1 TRADE ANALYSIS FOR UDDER HEALTH PRODUCTS
  • 5.10 PRICING ANALYSIS
    • 5.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TYPE
    • 5.10.2 AVERAGE SELLING PRICE TREND OF UDDER HEALTH PRODUCTS, BY REGION
  • 5.11 REIMBURSEMENT ANALYSIS
  • 5.12 KEY CONFERENCES AND EVENTS (2024-2025)
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.13.2 BUYING CRITERIA
  • 5.14 UNMET NEEDS/END-USER EXPECTATIONS IN UDDER HEALTH MARKET
  • 5.15 ECOSYSTEM ANALYSIS
  • 5.16 CASE STUDY ANALYSIS
    • 5.16.1 EARLY MASTITIS DETECTION WITH SENSOR TECHNOLOGY
    • 5.16.2 AUTOMATION OF PRE-TEAT DIPPING FOR HIGH EFFICIENCY
    • 5.16.3 UTILIZING HERD MANAGEMENT SOFTWARE FOR DATA-DRIVEN DECISIONS
  • 5.17 SUPPLY CHAIN ANALYSIS
  • 5.18 ADJACENT MARKETS
  • 5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.20 INVESTMENT & FUNDING SCENARIO

6 UDDER HEALTH MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 DEVICES
    • 6.2.1 MILK QUALITY ANALYZERS
      • 6.2.1.1 Ability to ensure quality & safety to drive market
    • 6.2.2 MILK SAMPLING EQUIPMENT
      • 6.2.2.1 Growing demand for automated sampling systems and manual sampling kits to drive market
    • 6.2.3 MILK MANAGEMENT SYSTEMS
      • 6.2.3.1 Rising technological advancements to support market growth
    • 6.2.4 OTHER UDDER HEALTH DEVICES
  • 6.3 PHARMACEUTICALS
    • 6.3.1 ANTIBIOTICS
      • 6.3.1.1 Advancements in formulations and delivery methods to propel market
    • 6.3.2 VACCINES
      • 6.3.2.1 Growth in dairy farm sector to boost demand
    • 6.3.3 ANTI-INFLAMMATORY DRUGS
      • 6.3.3.1 Innovative product launches to support market growth
    • 6.3.4 INTRAMAMMARY INFUSIONS
      • 6.3.4.1 Ability to provide targeted treatment during dry season to drive market
    • 6.3.5 TEAT SEALANTS
      • 6.3.5.1 Antimicrobial properties to drive market
    • 6.3.6 OTHER UDDER HEALTH PHARMACEUTICALS
  • 6.4 SUPPLEMENTS
    • 6.4.1 VITAMINS & MINERALS
      • 6.4.1.1 Essential requirement for optimal health of dairy cattle to fuel uptake
    • 6.4.2 PROBIOTICS & PREBIOTICS
      • 6.4.2.1 Growing demand for nutraceuticals to drive market
    • 6.4.3 OTHER UDDER HEALTH SUPPLEMENTS

7 UDDER HEALTH MARKET, BY VETERINARY CARE SETTING

  • 7.1 INTRODUCTION
  • 7.2 DAIRY FARMS
    • 7.2.1 GROWING DEMAND FOR MILK & DAIRY PRODUCTS TO DRIVE MARKET
  • 7.3 VETERINARY HOSPITALS AND CLINICS
    • 7.3.1 INCREASING ESTABLISHMENT OF CLINICAL PRACTICES ACROSS EMERGING ECONOMIES TO SUPPORT MARKET GROWTH

8 UDDER HEALTH MARKET, BY ANIMAL TYPE

  • 8.1 INTRODUCTION
  • 8.2 DAIRY CATTLE
    • 8.2.1 GROWTH IN CATTLE POPULATION TO DRIVE MARKET
  • 8.3 OTHER ANIMAL TYPES

9 UDDER HEALTH MARKET, BY DISEASE TYPE

  • 9.1 INTRODUCTION
  • 9.2 CLINICAL MASTITIS
    • 9.2.1 INCREASING PREVALENCE AND HIGH COSTS ASSOCIATED WITH TREATMENT TO PROPEL MARKET
  • 9.3 OTHER DISEASE TYPES

10 UDDER HEALTH MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 NORTH AMERICA: RECESSION IMPACT
    • 10.2.2 US
      • 10.2.2.1 Increasing number of veterinary practitioners to drive market
    • 10.2.3 CANADA
      • 10.2.3.1 High R&D investments for udder monitoring products to drive market
  • 10.3 EUROPE
    • 10.3.1 EUROPE: RECESSION IMPACT
    • 10.3.2 GERMANY
      • 10.3.2.1 Advanced dairy farming practices to fuel uptake
    • 10.3.3 UK
      • 10.3.3.1 High adoption of advanced veterinary technologies to propel market
    • 10.3.4 FRANCE
      • 10.3.4.1 Expanding dairy industry to support market growth
    • 10.3.5 ITALY
      • 10.3.5.1 Growing investments in udder health solutions to drive market
    • 10.3.6 SWITZERLAND
      • 10.3.6.1 Growing demand for mastitis detectors to fuel uptake
    • 10.3.7 SPAIN
      • 10.3.7.1 Increasing establishment of dairy farms to boost demand
    • 10.3.8 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 ASIA PACIFIC: RECESSION IMPACT
    • 10.4.2 JAPAN
      • 10.4.2.1 Growing focus on automated milking systems to boost demand
    • 10.4.3 CHINA
      • 10.4.3.1 Increase in milk consumption to propel market
    • 10.4.4 INDIA
      • 10.4.4.1 Growing population of dairy cattle to drive market
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 Stringent dairy farming regulations to propel market
    • 10.4.6 SOUTH KOREA
      • 10.4.6.1 Increasing awareness and adoption of preventive healthcare measures among dairy farmers to drive market
    • 10.4.7 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 LATIN AMERICA: RECESSION IMPACT
    • 10.5.2 BRAZIL
      • 10.5.2.1 Emphasis on improving milk quality to boost demand
    • 10.5.3 MEXICO
      • 10.5.3.1 Improvements in animal welfare standards to support market growth
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
    • 10.6.2 GCC COUNTRIES
      • 10.6.2.1 Improvements in economic stability to support market growth
    • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN UDDER HEALTH MARKET
  • 11.3 REVENUE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
    • 11.4.1 RANKING OF KEY MARKET PLAYERS
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.5.5.1 Company footprint
      • 11.5.5.2 Region footprint
      • 11.5.5.3 Product footprint
      • 11.5.5.4 Veterinary care setting footprint
      • 11.5.5.5 Animal type footprint
      • 11.5.5.6 Disease type footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 11.7 COMPANY VALUATION AND FINANCIAL METRICS
    • 11.7.1 FINANCIAL METRICS
    • 11.7.2 COMPANY VALUATION
  • 11.8 R&D EXPENDITURE OF KEY PLAYERS
  • 11.9 BRAND/PRODUCT COMPARISON
  • 11.10 COMPETITIVE SCENARIO
    • 11.10.1 PRODUCT LAUNCHES & APPROVALS
    • 11.10.2 DEALS
    • 11.10.3 EXPANSIONS
    • 11.10.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 VETOQUINOL S.A.
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Deals
        • 12.1.1.3.2 Other developments
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Key strengths
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses & competitive threats
    • 12.1.2 ZOETIS INC.
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products offered
      • 12.1.2.3 Recent developments
        • 12.1.2.3.1 Product launches
        • 12.1.2.3.2 Expansions
      • 12.1.2.4 MnM view
        • 12.1.2.4.1 Key strengths
        • 12.1.2.4.2 Strategic choices
        • 12.1.2.4.3 Weaknesses & competitive threats
    • 12.1.3 MERCK & CO., INC.
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Product launches & approvals
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Key strengths
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses & competitive threats
    • 12.1.4 VIRBAC
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
      • 12.1.4.3 MnM view
        • 12.1.4.3.1 Key strengths
        • 12.1.4.3.2 Strategic choices
        • 12.1.4.3.3 Weaknesses & competitive threats
    • 12.1.5 ECOLAB
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Product launches
        • 12.1.5.3.2 Deals
    • 12.1.6 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products offered
      • 12.1.6.3 MnM view
        • 12.1.6.3.1 Key strengths
        • 12.1.6.3.2 Strategic choices
        • 12.1.6.3.3 Weaknesses & competitive threats
    • 12.1.7 ELANCO ANIMAL HEALTH INCORPORATED
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products offered
    • 12.1.8 DELAVAL
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products offered
      • 12.1.8.3 Recent developments
        • 12.1.8.3.1 Product launches
        • 12.1.8.3.2 Other developments
    • 12.1.9 ORFFA
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products offered
      • 12.1.9.3 Recent developments
        • 12.1.9.3.1 Deals
    • 12.1.10 AHV INTERNATIONAL B.V.
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products offered
    • 12.1.11 BOUMATIC LLC
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products offered
    • 12.1.12 GEA GROUP AKTIENGESELLSCHAFT
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products offered
    • 12.1.13 G SHEPHERD ANIMAL HEALTH
      • 12.1.13.1 Business overview
      • 12.1.13.2 Products offered
      • 12.1.13.3 Recent developments
        • 12.1.13.3.1 Other developments
    • 12.1.14 CEVA SANTE ANIMALE
      • 12.1.14.1 Business overview
      • 12.1.14.2 Products offered
  • 12.2 OTHER PLAYERS
    • 12.2.1 ALBERT KERBL GMBH: COMPANY OVERVIEW
    • 12.2.2 AMBIC EQUIPMENT LIMITED: COMPANY OVERVIEW
    • 12.2.3 LELY: COMPANY OVERVIEW
    • 12.2.4 ZENEX ANIMAL HEALTH INDIA PRIVATE LTD.: COMPANY OVERVIEW
    • 12.2.5 DRAMINSKI S. A.: COMPANY OVERVIEW
    • 12.2.6 RING BIOTECHNOLOGY CO LTD.: COMPANY OVERVIEW
    • 12.2.7 NICOSIA BIOLABS INTERNATIONAL PRIVATE LIMITED: COMPANY OVERVIEW
    • 12.2.8 BLACKMANGO HERBS: COMPANY OVERVIEW
    • 12.2.9 KORU DIAGNOSTICS LTD.: COMPANY OVERVIEW
    • 12.2.10 MASTAPLEX: COMPANY OVERVIEW
    • 12.2.11 ARBROWN CO., JP LTD.: COMPANY OVERVIEW

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD)
  • TABLE 2 STUDY ASSUMPTION ANALYSIS
  • TABLE 3 UDDER HEALTH MARKET: RISK ASSESSMENT ANALYSIS
  • TABLE 4 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 UDDER HEALTH: LIST OF MAJOR PATENTS
  • TABLE 9 IMPORT AND EXPORT DATA FOR UDDER HEALTH PRODUCTS, BY COUNTRY
  • TABLE 10 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY TYPE
  • TABLE 11 AVERAGE SELLING PRICE OF UDDER HEALTH PRODUCTS, BY REGION
  • TABLE 12 UDDER HEALTH MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
  • TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
  • TABLE 14 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 15 UDDER HEALTH MARKET: ROLE IN ECOSYSTEM
  • TABLE 16 CASE STUDY 1: EARLY MASTITIS DETECTION WITH SENSOR TECHNOLOGY
  • TABLE 17 CASE STUDY 2: AUTOMATION OF PRE-TEAT DIPPING FOR EFFICIENCY
  • TABLE 18 CASE STUDY 3: UTILIZING HERD MANAGEMENT SOFTWARE FOR DATA-DRIVEN DECISIONS
  • TABLE 19 UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 20 UDDER HEALTH MARKET FOR DEVICES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 21 MILK QUALITY ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 22 MILK SAMPLING EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 23 MILK MANAGEMENT SYSTEMS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 24 OTHER UDDER HEALTH DEVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 25 UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 26 ANTIBIOTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 27 VACCINES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 28 ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 29 INTRAMAMMARY INFUSIONS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 30 TEAT SEALANTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 31 OTHER UDDER HEALTH PHARMACEUTICALS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 32 UDDER HEALTH MARKET FOR SUPPLEMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 33 VITAMINS & MINERALS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 34 PROBIOTICS & PREBIOTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 35 OTHER UDDER HEALTH SUPPLEMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 36 UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 37 UDDER HEALTH MARKET FOR DAIRY FARMS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 38 UDDER HEALTH MARKET FOR VETERINARY HOSPITALS AND CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 39 UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 40 UDDER HEALTH MARKET FOR DAIRY CATTLE, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 41 UDDER HEALTH MARKET FOR OTHER ANIMAL TYPES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 42 UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 43 UDDER HEALTH MARKET FOR CLINICAL MASTITIS, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 44 UDDER HEALTH MARKET FOR OTHER DISEASE TYPES, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 45 UDDER HEALTH MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 46 NORTH AMERICA: UDDER HEALTH MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 47 NORTH AMERICA: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 48 NORTH AMERICA: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (THOUSAND UNITS)
  • TABLE 49 NORTH AMERICA: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 50 NORTH AMERICA: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 51 NORTH AMERICA: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 52 NORTH AMERICA: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 53 NORTH AMERICA: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 54 NORTH AMERICA: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 55 US: KEY MACROINDICATORS
  • TABLE 56 US: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 57 US: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 58 US: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 59 US: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 60 US: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 61 US: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 62 US: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 63 CANADA: KEY MACROINDICATORS
  • TABLE 64 CANADA: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 65 CANADA: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 66 CANADA: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 67 CANADA: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 68 CANADA: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 69 CANADA: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 70 CANADA: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 71 EUROPE: UDDER HEALTH MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 72 EUROPE: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 73 EUROPE: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (THOUSAND UNITS)
  • TABLE 74 EUROPE: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 75 EUROPE: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 76 EUROPE: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 77 EUROPE: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 78 EUROPE: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 79 EUROPE: UDDER HEALTH MARKET, BY DISEASE TYPE 2022-2029 (USD MILLION)
  • TABLE 80 GERMANY: KEY MACROINDICATORS
  • TABLE 81 GERMANY: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 82 GERMANY: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 83 GERMANY: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION) 2022-2029 (USD MILLION)
  • TABLE 84 GERMANY: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 85 GERMANY: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 86 GERMANY: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 87 GERMANY: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 88 UK: KEY MACROINDICATORS
  • TABLE 89 UK: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 90 UK: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 91 UK: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 92 UK: UDDER HEALTH MARKT FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 93 UK: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 94 UK: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 95 UK: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 96 FRANCE: KEY MACROINDICATORS
  • TABLE 97 FRANCE: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 98 FRANCE: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 99 FRANCE: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 100 FRANCE: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 101 FRANCE: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 102 FRANCE: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 103 FRANCE: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 104 ITALY: KEY MACROINDICATORS
  • TABLE 105 ITALY: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 106 ITALY: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 107 ITALY: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 108 ITALY: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 109 ITALY: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 110 ITALY: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 111 ITALY: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 112 SWITZERLAND: KEY MACROINDICATORS
  • TABLE 113 SWITZERLAND: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 114 SWITZERLAND: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 115 SWITZERLAND: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION) 2022-2029 (USD MILLION)
  • TABLE 116 SWITZERLAND: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 117 SWITZERLAND: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 118 SWITZERLAND: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 119 SWITZERLAND: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 120 SPAIN: KEY MACROINDICATORS
  • TABLE 121 SPAIN: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 122 SPAIN: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 123 SPAIN: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 124 SPAIN: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 125 SPAIN: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 126 SPAIN: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 127 SPAIN: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 128 REST OF EUROPE: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 129 REST OF EUROPE: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 130 REST OF EUROPE: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 131 REST OF EUROPE: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 132 REST OF EUROPE: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 133 REST OF EUROPE: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 134 REST OF EUROPE: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 135 ASIA PACIFIC: UDDER HEALTH MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 136 ASIA PACIFIC: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 137 ASIA PACIFIC: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (THOUSAND UNITS)
  • TABLE 138 ASIA PACIFIC: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 140 ASIA PACIFIC: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 144 JAPAN: KEY MACROINDICATORS
  • TABLE 145 JAPAN: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 146 JAPAN: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 147 JAPAN: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 148 JAPAN: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 149 JAPAN: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 150 JAPAN: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 151 JAPAN: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 152 CHINA: KEY MACROINDICATORS
  • TABLE 153 CHINA: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 154 CHINA: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 155 CHINA: UDDER HEALTH MARKET, BY PHARMACEUTICALS 2022-2029 (USD MILLION)
  • TABLE 156 CHINA: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 157 CHINA: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 158 CHINA: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 159 CHINA: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 160 INDIA: KEY MACROINDICATORS
  • TABLE 161 INDIA: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 162 INDIA: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 163 INDIA: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 164 INDIA: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 165 INDIA: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 166 INDIA: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 167 INDIA: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 168 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 169 AUSTRALIA: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 170 AUSTRALIA: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 171 AUSTRALIA: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 172 AUSTRALIA: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 173 AUSTRALIA: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 174 AUSTRALIA: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 175 AUSTRALIA: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 176 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 177 SOUTH KOREA: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 178 SOUTH KOREA: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 179 SOUTH KOREA: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 180 SOUTH KOREA: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 181 SOUTH KOREA: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 182 SOUTH KOREA: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 183 SOUTH KOREA: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 184 REST OF ASIA PACIFIC: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 185 REST OF ASIA PACIFIC: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 186 REST OF ASIA PACIFIC: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 187 REST OF ASIA PACIFIC: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 188 REST OF ASIA PACIFIC: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 189 REST OF ASIA PACIFIC: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 190 REST OF ASIA PACIFIC: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 191 LATIN AMERICA: UDDER HEALTH MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 192 LATIN AMERICA: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 193 LATIN AMERICA: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (THOUSAND UNIT)
  • TABLE 194 LATIN AMERICA: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 195 LATIN AMERICA: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 196 LATIN AMERICA: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 197 LATIN AMERICA: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 198 LATIN AMERICA: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 199 LATIN AMERICA: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 200 BRAZIL: KEY MACROINDICATORS
  • TABLE 201 BRAZIL: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 202 BRAZIL: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 203 BRAZIL: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 204 BRAZIL: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 205 BRAZIL: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 206 BRAZIL: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 207 BRAZIL: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 208 MEXICO: KEY MACROINDICATORS
  • TABLE 209 MEXICO: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 210 MEXICO: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 211 MEXICO: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 212 MEXICO: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 213 MEXICO: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 214 MEXICO: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 215 MEXICO: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 216 REST OF LATIN AMERICA: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 217 REST OF LATIN AMERICA: UDDER HEALTH MARKET, BY DEVICES, 2022-2029 (USD MILLION)
  • TABLE 218 REST OF LATIN AMERICA: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)2022-2029 (USD MILLION)
  • TABLE 219 REST OF LATIN AMERICA: UDDER HEALTH MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 220 REST OF LATIN AMERICA: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 221 REST OF LATIN AMERICA: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 222 REST OF LATIN AMERICA: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 223 MIDDLE EAST & AFRICA: UDDER HEALTH MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 224 MIDDLE EAST & AFRICA: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 225 MIDDLE EAST & AFRICA: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (THOUSAND UNITS)
  • TABLE 226 MIDDLE EAST & AFRICA: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 227 MIDDLE EAST & AFRICA: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 228 MIDDLE EAST & AFRICA: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 229 MIDDLE EAST & AFRICA: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 230 MIDDLE EAST & AFRICA: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 231 MIDDLE EAST & AFRICA: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 232 GCC COUNTRIES: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 233 GCC COUNTRIES: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 234 GCC COUNTRIES: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 235 GCC COUNTRIES: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 236 GCC COUNTRIES: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 237 GCC COUNTRIES: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 238 GCC COUNTRIES: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 239 REST OF MIDDLE EAST & AFRICA: UDDER HEALTH MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
  • TABLE 240 REST OF MIDDLE EAST & AFRICA: UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 241 REST OF MIDDLE EAST & AFRICA: UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 242 REST OF MIDDLE EAST & AFRICA: UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 243 REST OF MIDDLE EAST & AFRICA: UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2022-2029 (USD MILLION)
  • TABLE 244 REST OF MIDDLE EAST & AFRICA: UDDER HEALTH MARKET, BY ANIMAL TYPE, 2022-2029 (USD MILLION)
  • TABLE 245 REST OF MIDDLE EAST & AFRICA: UDDER HEALTH MARKET, BY DISEASE TYPE, 2022-2029 (USD MILLION)
  • TABLE 246 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS
  • TABLE 247 UDDER HEALTH MARKET: REGION FOOTPRINT
  • TABLE 248 UDDER HEALTH MARKET: PRODUCT FOOTPRINT
  • TABLE 249 UDDER HEALTH MARKET: VETERINARY CARE SETTINGS FOOTPRINT
  • TABLE 250 UDDER HEALTH MARKET: ANIMAL TYPE FOOTPRINT
  • TABLE 251 UDDER HEALTH MARKET: DISEASE TYPE FOOTPRINT
  • TABLE 252 UDDER HEALTH MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 253 UDDER HEALTH MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 254 UDDER HEALTH MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2020-MAY 2024
  • TABLE 255 UDDER HEALTH MARKET: DEALS, JANUARY 2020-MAY 2024
  • TABLE 256 UDDER HEALTH MARKET: EXPANSIONS, JANUARY 2020-MAY 2024
  • TABLE 257 UDDER HEALTH MARKET: OTHER DEVELOPMENTS, JANUARY 2020-MAY 2024
  • TABLE 258 VETOQUINOL S.A.: COMPANY OVERVIEW
  • TABLE 259 VETOQUINOL S.A.: PRODUCTS OFFERED
  • TABLE 260 VETOQUINOL S.A.: DEALS, JANUARY 2020-MAY 2024
  • TABLE 261 VETOQUINOL S.A.: OTHER DEVELOPMENTS, JANUARY 2020-MAY 2024
  • TABLE 262 ZOETIS INC.: COMPANY OVERVIEW
  • TABLE 263 ZOETIS INC: PRODUCTS OFFERED
  • TABLE 264 ZOETIS INC.: PRODUCT LAUNCHES, JANUARY 2020-MAY 2024
  • TABLE 265 ZOETIS INC.: EXPANSIONS, JANUARY 2020-MAY 2024
  • TABLE 266 MERCK & CO., INC.: COMPANY OVERVIEW
  • TABLE 267 MERCK & CO., INC.: PRODUCTS OFFERED
  • TABLE 268 MERCK & CO., INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2020-MAY 2024
  • TABLE 269 VIRBAC: COMPANY OVERVIEW
  • TABLE 270 VIRBAC: PRODUCTS OFFERED
  • TABLE 271 ECOLAB: COMPANY OVERVIEW
  • TABLE 272 ECOLAB: PRODUCTS OFFERED
  • TABLE 273 ECOLAB: PRODUCT LAUNCHES, JANUARY 2020-MAY 2024
  • TABLE 274 ECOLAB: DEALS, JANUARY 2020-MAY 2024
  • TABLE 275 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY OVERVIEW
  • TABLE 276 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: PRODUCTS OFFERED
  • TABLE 277 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY OVERVIEW
  • TABLE 278 ELANCO ANIMAL HEALTH INCORPORATED: PRODUCTS OFFERED
  • TABLE 279 DELAVAL: COMPANY OVERVIEW
  • TABLE 280 DALAVAL: PRODUCTS OFFERED
  • TABLE 281 DELAVAL: PRODUCT LAUNCHES, JANUARY 2021-MAY 2024
  • TABLE 282 DELAVAL: OTHER DEVELOPMENTS, JANUARY 2020-MAY 2024
  • TABLE 283 ORFFA: COMPANY OVERVIEW
  • TABLE 284 ORFFA: PRODUCTS OFFERED
  • TABLE 285 ORFFA: DEALS, JANUARY 2020-MAY 2024
  • TABLE 286 AHV INTERNATIONAL B.V.: COMPANY OVERVIEW
  • TABLE 287 AHV INTERNATIONAL B.V.: PRODUCTS OFFERED
  • TABLE 288 BOUMATIC LLC: COMPANY OVERVIEW
  • TABLE 289 BOUMATIC LLC: PRODUCTS OFFERED
  • TABLE 290 GEA GROUP AKTIENGESELLSCHAFT: COMPANY OVERVIEW
  • TABLE 291 GEA GROUP AKTIENGESELLSCHAFT: PRODUCTS OFFERED
  • TABLE 292 G SHEPHERD ANIMAL HEALTH: COMPANY OVERVIEW
  • TABLE 293 G SHEPHERD ANIMAL HEALTH: PRODUCTS OFFERED
  • TABLE 294 G SHEPHERD ANIMAL HEALTH: OTHER DEVELOPMENTS, JANUARY 2020-MAY 2024
  • TABLE 295 CEVA SANTE ANIMALE: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 UDDER HEALTH MARKET SEGMENTATION
  • FIGURE 2 UDDER HEALTH MARKET: REGIONS COVERED
  • FIGURE 3 RESEARCH DESIGN
  • FIGURE 4 PRIMARY SOURCES
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY VETERINARY CARE SETTING, DESIGNATION, AND REGION
  • FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 9 REVENUE SHARE ANALYSIS ILLUSTRATION OF ZOETIS INC.
  • FIGURE 10 SUPPLY-SIDE ANALYSIS: UDDER HEALTH MARKET (2023)
  • FIGURE 11 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024-2029)
  • FIGURE 12 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
  • FIGURE 13 TOP-DOWN APPROACH
  • FIGURE 14 MARKET DATA TRIANGULATION METHODOLOGY
  • FIGURE 15 UDDER HEALTH MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 UDDER HEALTH MARKET FOR DEVICES, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 17 UDDER HEALTH MARKET FOR PHARMACEUTICALS, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 18 UDDER HEALTH MARKET FOR SUPPLEMENTS, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 19 UDDER HEALTH MARKET, BY VETERINARY CARE SETTING, 2024 VS. 2029 (USD MILLION)
  • FIGURE 20 UDDER HEALTH MARKET, BY ANIMAL TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 21 UDDER HEALTH MARKET, BY DISEASE TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 22 GEOGRAPHIC SNAPSHOT OF UDDER HEALTH MARKET
  • FIGURE 23 INCREASING INCIDENCE OF MASTITIS AND GROWING FOCUS ON PREVENTIVE CARE TO DRIVE MARKET
  • FIGURE 24 PHARMACEUTICALS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 25 ASIA PACIFIC SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 26 CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 27 UDDER HEALTH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 28 PRODUCTION OF MILK AND MILK PRODUCTS BY REGION (IN THOUSAND TONNES-MILK EQUIVALENT)
  • FIGURE 29 TOTAL NUMBER OF VETERINARIANS IN US, BY GENDER (2019-2023)
  • FIGURE 30 NUMBER OF VETERINARIANS IN TOP FIVE EUROPEAN COUNTRIES (2023)
  • FIGURE 31 UDDER HEALTH MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 32 UDDER HEALTH MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 33 DEVELOPMENT & APPROVAL PROCESS FOR ANIMAL PHARMACEUTICAL PRODUCTS
  • FIGURE 34 PATENT PUBLICATION TRENDS (JANUARY 2013-DECEMBER 2023)
  • FIGURE 35 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR UDDER HEALTH PATENTS (JANUARY 2013-DECEMBER 2023)
  • FIGURE 36 TOP APPLICANT COUNTRIES/REGIONS FOR UDDER HEALTH PATENTS (JANUARY 2013-DECEMBER 2023)
  • FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
  • FIGURE 38 KEY BUYING CRITERIA FOR END USERS
  • FIGURE 39 ECOSYSTEM MARKET/MAP
  • FIGURE 40 UDDER HEALTH MARKET: ROLE IN ECOSYSTEM
  • FIGURE 41 UDDER HEALTH MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 42 ADJACENT MARKETS FOR UDDER HEALTH MARKET
  • FIGURE 43 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 44 INVESTMENT/VENTURE CAPITAL SCENARIO IN UDDER HEALTH MARKET, 2019-2023
  • FIGURE 45 EUROPE: UDDER HEALTH MARKET SNAPSHOT
  • FIGURE 46 ASIA PACIFIC: UDDER HEALTH MARKET SNAPSHOT
  • FIGURE 47 REVENUE ANALYSIS OF KEY PLAYERS IN UDDER HEALTH MARKET (2019-2023)
  • FIGURE 48 MARKET SHARE ANALYSIS OF KEY PLAYERS IN UDDER HEALTH MARKET (2023)
  • FIGURE 49 RANKING OF KEY PLAYERS IN UDDER HEALTH MARKET, 2023
  • FIGURE 50 UDDER HEALTH MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 51 UDDER HEALTH MARKET: COMPANY FOOTPRINT
  • FIGURE 52 UDDER HEALTH MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 53 EV/EBITDA OF KEY VENDORS L
  • FIGURE 54 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 55 R&D EXPENDITURE OF KEY PLAYERS IN UDDER HEALTH MARKET, 2021-2023
  • FIGURE 56 BRAND/PRODUCT COMPARISON ANALYSIS
  • FIGURE 57 VETOQUINOL S.A.: COMPANY SNAPSHOT (2023)
  • FIGURE 58 ZOETIS INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 59 MERCK & CO., INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 60 VIRBAC: COMPANY SNAPSHOT (2023)
  • FIGURE 61 ECOLAB: COMPANY SNAPSHOT (2023)
  • FIGURE 62 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT (2023)
  • FIGURE 63 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT (2023)
  • FIGURE 64 DELAVAL: COMPANY SNAPSHOT (2023)
  • FIGURE 65 GEA GROUP AKTIENGESELLSCHAFT: COMPANY SNAPSHOT (2023)